Table 2 Summary of KRAS and TP53 mutation analysis, microsatellite analysis and immunohistochemistry

From: Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma

Case

Sex/age

Mutation analysis

Immunohistochemistry

MSI

LOH

  

TP53

KRAS

TP53

CDKN1A

SMAD4

CTNNB1

  

PJS1

M/45

WT

WT

0

+

Membranous

MSS

D17S250, D5S346

T1

M/48

S & MS

WT

+

2

+

Membranous

MSS

 

T2

F/68

WT

WT

0

+

Nuclear

MSS

 

T3

M/61

WT

WT

2

Membranous

MSS

D17S250

T4

F/19

WT

WT

0

+

Membranous

MSS

 

T5

M/33

NAa

NAa

1

+

Membranous

MSS

 
  1. Abbreviations: M, male; F, female; PJS, Peutz-Jeghers syndrome; WT, wild type; S, silent mutation; MS, missense mutation; MSI, microsatellite instability; MSS, microsatellite stable; LOH, loss of heterozygosity; NA, not applicable.
  2. For TP53-normal negative labeling; +, positive labeling. For CDKN1A: 0, absent labeling; 1, weak positive labeling; 2, strong positive labeling. For SMAD4-absent labeling; +, normal positive labeling. For CTNNB1: N, normal membraneous (negative); F, focal nuclear labeling (positive).
  3. aInsufficiënt DNA.